KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Inventory Average (2017 - 2025)

Historic Inventory Average for BeOne Medicines (ONC) over the last 9 years, with Q3 2025 value amounting to $517.3 million.

  • BeOne Medicines' Inventory Average rose 1824.34% to $517.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $517.3 million, marking a year-over-year increase of 1824.34%. This contributed to the annual value of $455.6 million for FY2024, which is 3044.38% up from last year.
  • Latest data reveals that BeOne Medicines reported Inventory Average of $517.3 million as of Q3 2025, which was up 1824.34% from $498.8 million recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Inventory Average registered a high of $517.3 million during Q3 2025, and its lowest value of $81.1 million during Q1 2021.
  • Over the past 5 years, BeOne Medicines' median Inventory Average value was $309.2 million (recorded in 2023), while the average stood at $323.3 million.
  • As far as peak fluctuations go, BeOne Medicines' Inventory Average soared by 29059.03% in 2021, and later skyrocketed by 1200.55% in 2025.
  • BeOne Medicines' Inventory Average (Quarter) stood at $196.8 million in 2021, then surged by 45.64% to $286.6 million in 2022, then increased by 27.87% to $366.5 million in 2023, then grew by 26.41% to $463.3 million in 2024, then grew by 11.64% to $517.3 million in 2025.
  • Its last three reported values are $517.3 million in Q3 2025, $498.8 million for Q2 2025, and $494.8 million during Q1 2025.